News Image

Tonix Pharmaceuticals Announces FDA Approval of Tonmyaâ„¢ (cyclobenzaprine HCl sublingual tablets) for the Treatment of Fibromyalgia

Provided By GlobeNewswire

Last update: Aug 15, 2025

Tonmya is the first FDA-approved therapy for the treatment of fibromyalgia in over 15 years

Fibromyalgia is a chronic pain condition that affects more than 10 million adults in the U.S. who are mostly women

Read more at globenewswire.com

TONIX PHARMACEUTICALS HOLDIN

NASDAQ:TNXP (8/15/2025, 8:00:01 PM)

After market: 59.31 +7.96 (+15.5%)

51.35

-8.23 (-13.81%)



Find more stocks in the Stock Screener

TNXP Latest News and Analysis

Follow ChartMill for more